Clinical Trials Logo

Clinical Trial Summary

The study is a single-center prospective cohort study of clinical application of continuously monitored data by wearable activity trackers in the patients with thyrotoxicosis. The purpose of the study is to evaluate the association between parameters of pulse rate, activity, and sleep from wearable activity trackers and the thyrotoxic status along with the treatment.


Clinical Trial Description

Activity trackers to be used: Fitbit Charge HR (TM)

Data which ware provided by Fitbit app (TM) will be analyzed in this study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03009357
Study type Observational
Source Seoul National University Bundang Hospital
Contact
Status Completed
Phase
Start date November 2016
Completion date August 2017

See also
  Status Clinical Trial Phase
Completed NCT02973802 - ATX-GD-59 in Patients With Graves Disease Not Treated With Anti-thyroid Therapy Phase 1
Completed NCT02491567 - DNA Methylation and Autoimmune Thyroid Diseases
Terminated NCT01320813 - Trial Comparing Complication Rates Associated With Robot-assisted Thyroidectomy to External Thyroidectomy N/A
Completed NCT00432146 - Effect of Lugol's Solution in the Patients With Graves' Disease N/A
Completed NCT01727973 - Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy Phase 1/Phase 2
Active, not recruiting NCT04135573 - The Relationship Between NK Cell and Graves' Disease
Recruiting NCT03303053 - Efficacy and Safety of Cholestyramine and Prednisolone as Adjunctive Therapy in Treatment of Overt Hyperthyroidism Phase 3
Not yet recruiting NCT04239521 - The Epidemiology, Management, and the Associated Burden of Mental Health, Atopic and Autoimmune Conditions in Alopecia Areata
Completed NCT00782366 - Predictive Genetic Risk Assessment Trial N/A
Enrolling by invitation NCT04789993 - Additional Autoimmune Diseases With Type 1 Diabetes in Pediatrics at Diabetes Diagnosis and During Follow-up
Recruiting NCT03066076 - Total Thyroidectomy Versus Thionamides in Patients With Moderate-to-Severe Graves' Ophthalmopathy Phase 3
Recruiting NCT04932135 - Resting Heart Rate Monitoring for Optimized Treatment and Surveillance of Hyperthyroidism
Completed NCT02376088 - Characteristics of Islet β-cell Functions in Chinese Patients With Graves' Disease N/A
Completed NCT01227499 - Differential Diagnosis of STA-PSV in Thyrotoxicosis N/A
Completed NCT03498417 - Anti-insulin-like Growth Factor-1 Receptor (IGF-1R) Antibodies in Graves' Disease and Graves' Orbitopathy
Recruiting NCT02203682 - Doxycycline Treatment in Mild Graves' Orbitopathy Phase 2
Completed NCT02993302 - Effects Of Oral Alfacalcidol On Maturation Of Dendritic Cells In Graves' Disease Patients Phase 2
Completed NCT00677469 - Low Doses of Cholestyramine in the Treatment of Hyperthyroidism N/A
Completed NCT00796913 - Remission Induction and Sustenance in Graves' Disease 2 N/A
Completed NCT00150137 - Antithyroid Drugs During Radioiodine Therapy Phase 4